Dopamine receptor D2 Ser/Cys311 variant associated with disorganized symptomatology of schizophrenia

Schizophrenia Research

Volumn 34, Issue 3, 1998, Pages 207-210

  Serretti, Alessandro ^a   Macciardi, Fabio ^a   Smeraldi, Enrico ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Dopamine receptor D2; Phenotype; Psychopathology; Schizophrenia

Indexed keywords

DOPAMINE RECEPTOR;

ADULT; ARTICLE; DELUSION; DEPRESSION; DISORIENTATION; FEMALE; GENETIC RISK; GENETIC VARIABILITY; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; SCHIZOPHRENIA; SYMPTOMATOLOGY;

ADULT; FEMALE; HUMANS; MALE; PHENOTYPE; RECEPTORS, DOPAMINE D2; SCHIZOPHRENIA;

EID: 0032583183     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(98)00093-0     Document Type: Article

References (30)

1. American Psychiatric Association, 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. APA, Washington DC.
2. Arinami, T., Itokawa, M., Enguchi, H., Tagaya, H., Yano, S., Shimizu, H., Hamaguchi, H., Toru, M., 1994. Association of dopamine D2 receptor molecular variant with schizophrenia. Lancet 343, 703-704.
3. Arinami, T., Itokawa, M., Aoki, J., Shibuya, H., Ookubo, Y., Iwawaki, A., Ota, K., Shimizu, H., Hamaguchi, H., Toru, M., 1996. Further association study on dopamine D2 receptor variant S311C in schizophrenia and affective disorders. Am. J. Med. Genet. 67, 133-138.
4. Balk, J., Picetti, R., Salardi, A., Thirlet, G., Dierich, A., Depaulls, A., Le Meur, M., Borrelli, E., 1995. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 377, 424-428.
5. Carey, G., 1994. Genetic association study in psychiatry: analytical evaluation and a recommendation. Am. J. Med. Genet. 54, 311-317.
6. Chen, C.H., Chien, S.H., Hwu, H.G., 1996. No association of dopamine D2 receptor molecular variant Cys311 and schizophrenia in Chinese patients. Am. J. Med. Genet. 67, 418-420.
7. Cohen, J., 1988. Statistical Power Analysis for the Behavioral Sciences. Lawrence Erlbaum, Hillsdale, New Jersey.
8. Craddock, M., Asherson, P., Owen, M.J., Williams, J., McGuffin, P., Farmer, A.E., 1996. Concurrent validity of the OPCRIT diagnostic system. Comparison of OPCRIT diagnoses with consensus best-estimate lifetime diagnoses. Br. J. Psychiatry 169, 58-63.
9. Crawford, F., Hoyne, J., Cai, X., Osborne, A., Poston, D., Zaglul, J., Dajani, N., Walsh, S., Bradley, R., Solomon, R., Mullan, M., 1996. Dopamine DRD2/Cys311 is not associated with chronic schizophrenia. Am. J. Med. Genet. 67, 483-484.
10. Endicott, J., Spitzer, R., 1978. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch. Gen. Psychiatry 35, 837-844.
11. Farmer, A.E., Williams, J., Jones, I., 1994. Phenotypic definitions of psychotic illness for molecular genetic research. Am. J. Med. Genet. 54, 365-371.
12. Goldman, D., Urbanek, M., Guenther, D., Robin, R., Long, J.C., 1997. Linkage and association of a functional DRD2 variant [Ser311Cys] and DRD2 markers to alcoholism, substance abuse and schizophrenia in Southwestern American Indians. Am. J. Med. Genet. 74, 386-394.
13. Grandy, D., Litt, M., Allen, L., Bunzow, J., Marchionni, M., Makam, H., Reed, L., Magenis, R., Civelli, O., 1989. The human D2 dopamine receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. Am. J. Hum. Genet. 45, 778-785.
14. Itokawa, M., Arinami, T., Futamura, N., Hamaguchi, H., Toru, M., 1993. A structural polymorphism of human dopamine D2 receptor, D2(Ser311→Cys). Biochem. Biophys. Res. Commun. 196, 1369-1375.
15. Lahiri, D., Nurnberger, J.J., 1991. A rapid non-enzyimatic method for the preparation of HMW DNA from blood for RFLP studies. Nucl. Acids Res. 19, 5444
16. Laurent, C., Bodeau-Pean, S., Campion, D., d'Amato, T., Jay, M., Dollfus, S., Thibault, F., Petit, M., Samolyk, D., Martinez, M. et al., 1994. No major role for the dopamine D2 receptor Ser→Cys311 mutation in schizophrenia. Psychiatr. Genet. 4, 229-230.
17. Levinson, D., 1997. Pragmatics and statistics in psychiatric genetics. Am. J. Med. Genet. 74, 220-222.
18. Liddle, P.F., Barnes, T.R.E., 1990. Syndromes of chronic schizophrenia. Br. J. Psychiatry 157, 558-561.
19. Maziade, M., Roy, M.A., Martinez, M., Cliche, D., Fournier, J.P., Garneau, Y., Nicole, L., Montgrain, N., Dion, C., Ponton, A.M., 1995. Negative, psychoticism, and disorganized dimensions in patients with familial schizophrenia or bipolar disorder: continuity and discontinuity between the major psychoses. Am. J. Psychiatry 152, 1458-1463.
20. McGuffin, P., Farmer, A., Harvey, I., 1991. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch. Gen. Psychiatry 48, 764-770.
21. Nanko, S., Hattori, M., Dai, X.Y., Fukuda, R., Kazamatsuri, H., 1994. DRD2 Ser311/Cys311 polymorphism in schizophrenia. Lancet 343, 1044
22. Nothen, M.M., Wildenauer, D., Cichon, S., Albus, M., Maier, W., Minges, J., Lichtermann, D., Bondy, B., Rietschel, M., Korner, J. et al., 1994. Dopamine D2 receptor molecular variant and schizophrenia. Lancet 343, 1301-1302.
23. Sasaki, T., Macciardi, F.M., Badri, F., Verga, M., Meltzer, H.Y., Lieberman, J., Howard, A., Bean, G., Joffe, R.T., Hudson, C.J., Kennedy, J.L., 1996. No evidence for association of dopamine D2 receptor variant (Ser311/Cys311) with major psychosis. Am. J. Med. Genet. 67, 415-417.
24. Seeman, P., 1987. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1, 133-152.
25. Serretti, A., Macciardi, F., Smeraldi, E., 1996. Identification of symptomatologic patterns common to major psychoses: proposal for a phenotype definition. Am. J. Med. Genet. 67, 393-400.
26. Shaikh, S., Collier, D., Arranz, M., Ball, D., Gill, M., Kerwin, R., 1994. DRD2 Ser311/Cys311 polymorphism in schizophrenia. Lancet 343, 1045-1046.
27. Sobell, J., Sigurdson, D., Heston, L., Sommer, S., 1994. S311C D2DR variant: no association with schizophrenia. Lancet 344, 621-622.
28. Tanaka, T., Igarashi, S., Onodera, O., Tanaka, H., Fukushima, N., Takahashi, M., Kameda, K., Tsuji, S., Ihda, S., 1996. Lack of association between dopamine D2 receptor gene Cys311 variant and schizophrenia. Am. J. Med. Genet. 67, 208-211.
29. Verga, M., Macciardi, F., Pedrini, S., Cohen, S., Smeraldi, E., 1997. No association of the Ser/Cys311 DRD2 molecular variant with schizophrenia using a classical case control study and the haplotype relative risk. Schizophrenia Res. 25, 117-121.
30. Williams, J., Farmer, A.E., Ackenheil, M., Kaufmann, C.A., McGuffin, P., 1996. A multicentre inter-rater reliability study using the OPCRIT computerized diagnostic system. Psychol. Med. 26, 775-783.